Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Asset Utilization Ratio (2016 - 2025)

Adma Biologics (ADMA) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.86 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 11.82% year-over-year to 0.86, compared with a TTM value of 0.86 through Dec 2025, down 11.82%, and an annual FY2025 reading of 0.92, down 12.09% over the prior year.
  • Asset Utilization Ratio was 0.86 for Q4 2025 at Adma Biologics, down from 0.87 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.03 in Q2 2024 and bottomed at 0.22 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.67, with a median of 0.68 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio skyrocketed 139.58% in 2022, then dropped 17.81% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.43 in 2021, then grew by 11.57% to 0.47 in 2022, then soared by 86.92% to 0.89 in 2023, then rose by 9.29% to 0.97 in 2024, then decreased by 11.82% to 0.86 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ADMA at 0.86 in Q4 2025, 0.87 in Q3 2025, and 0.89 in Q2 2025.